6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
5m ago	Yapi ve Kredi Bankasi : Successful issuance of 500 million US$ perpetual Additional Tier 1 Capital Transaction
10m ago	Crown Castle Names Kris Hinson as Chief Commercial Officer and Mark Lennon as Chief Information Officer
15m ago	Hovnanian Enterprises Reports Fiscal 2026 Second Quarter Results
15m ago	LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
15m ago	KKR Sells CIRCOR Aerospace to Parker Hannifin for $2.55 Billion

About

1.84USD+0.08 +4.55%

Closed • Updated at 13:31 GMT+00:00

Market Cap$125.80M

Volume1.77M

Beta2.23

RSI60.87

Gross Margin-70.86%

Health TechnologyMedical Specialties

Cardiff Oncology, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Cardiff Oncology Reports First Quarter 2026 Results and Provides Business Update

Cardiff Oncology to Host Key Opinion Leader Discussion on Onvansertib’s Promising Single-Agent Activity

Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting

Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth

Cardiff Oncology to Host Key Opinion Leader Discussion Focusing on First-Line RAS-mutated Metastatic Colorectal Cancer

Community Chat

Ask AI